Meridiem Capital Partners LP Insulet Corp Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
A detailed history of Meridiem Capital Partners LP transactions in Insulet Corp stock. As of the latest transaction made, Meridiem Capital Partners LP holds 12,634 shares of PODD stock, worth $3.95 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
12,634Holding current value
$3.95 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding PODD
# of Institutions
902Shares Held
63.2MCall Options Held
300KPut Options Held
465K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.73 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.9 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.74MShares$1.48 Billion0.31% of portfolio
-
State Street Corp Boston, MA3.06MShares$957 Million0.04% of portfolio
-
Baillie Gifford & CO2.09MShares$655 Million0.5% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $21.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...